Search

Your search keyword '"Zilli T"' showing total 502 results

Search Constraints

Start Over You searched for: Author "Zilli T" Remove constraint Author: "Zilli T"
502 results on '"Zilli T"'

Search Results

1. Keloid treatment: what about adjuvant radiotherapy?

5. PEACE V–Salvage Treatment of oligorecurrent nodal prostate cancer metastases (STORM): 24-months toxicity results of a randomized phase II trial

10. OC-0269 Early toxicity of SBRT for oligometastatic cancer patients in the EORTC/ESTRO OligoCare cohort

11. OC-0270 Metastases-directed SRT and systemic therapy: EORTC-ESTRO OligoCare delphi consensus recommendations

14. Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database

15. PEACE V – Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial

17. Radiothérapie de rattrapage guidée par l’imagerie fonctionnelle après rechute macroscopique dans la loge de prostatectomie : étude multicentrique rétrospective internationale

18. Salvage Radiotherapy Guided by Functional Imaging for Macroscopic Local Recurrence Following Radical Prostatectomy: A Multicentric Retrospective Study

21. OC-0603 PEACE V – STORM randomized phase II trial for oligorecurrent nodal prostate cancer: acute toxicity

22. OC-0609 Radiotherapy quality assurance of the PEACE-1 trial: Initial results of individual case reviews

24. OC-0607 Radiotherapy guided by functional imaging for macroscopic local recurrence following prostatectomy

25. OC-0599 Factors associated with SBRT doses in oligometastatic disease: an EORTC/ESTRO OligoCare analysis

26. PEACE V - STORM randomized phase II trial for oligorecurrent nodal prostate cancer: acute toxicity

27. PEACE V – Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute toxicity of a randomized phase II trial

28. Salvage Treatments for the Local Recurrence of Prostate Cancer After Radiotherapy – Results of an International Multidisciplinary Survey

30. PD-0740 Real-world patient & treatment characteristics of oligometastatic disease: results of OligoCare

33. PO-1712 Oligorecurrent nodal prostate cancer: radiotherapy QA of the randomized PEACE V-STORM phase II trial

35. Is hypofractionation acceptable for prostate bed radiotherapy?

36. A0644 - PEACE V–Salvage Treatment of oligorecurrent nodal prostate cancer metastases (STORM): 24-months toxicity results of a randomized phase II trial.

41. P-115 PEMREC: A phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized microsatellite stable rectal cancer

42. Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series

43. Imaging targeted treatments versus extended salvage lymph node dissection for patients with a single nodal recurrence of prostate cancer: A comparative analysis from a large multi-institutional series

44. P033 - Genomic classifiers in personalized prostate cancer radiotherapy approaches – a systematic review and future perspectives based on international consensus

47. Salvage-Radiotherapie bei makroskopischen Lokalrezidiven nach radikaler Prostatektomie : Nationale Umfrage zu Behandlungsmustern [Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy : A national survey on patterns of practice]

48. Single Fraction Urethra-Sparing Prostate Cancer SBRT: Phase I Results of a Multicenter, Single Arm, Phase I/II Trial

50. OC-0609 Urethra-sparing SBRT for prostate cancer: quality assurance of a randomized phase II trial

Catalog

Books, media, physical & digital resources